Riskpilot← Back to searchSign inGet full accessBarsoum MedTech Services AB
ABActiveOrg 5592399264Spångavägen 106Hospital activities · NACE 8610Est. 20200 employees
Revenue 2024
SEK 206K
EBITDA margin
86.6%
+50720% vs 2023
Equity ratio
76.2%
Financial strength
Net profit 2024
SEK 145K
+63154% vs 2023
| Revenue | SEK 206K | — |
| EBITDA | SEK 179K | +50720% |
| Net profit | SEK 145K | +63154% |
| Total assets | SEK 208K | +1489% |
| Equity | SEK 158K | +1110% |
| Employees | 0 | — |
Legal name
Barsoum MedTech Services AB
Org number
5592399264
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
3 februari 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Sälja konsultuppdrag samt rådgivning inom primär- och slutenvård, industriteknik, produktutveckling, undervisning, samt maskin-och hållfasthetsteknisk konstruktionsrådgivning och därmed förenlig verksamhet, samt investeringar.
Address
Spångavägen 106
Email
ebba.swedenhammar@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 13 | 6 | 0 | 0 | 206 |
| Staff expenses | — | — | — | — | −5 |
| EBITDA | −7 | −1 | −3 | −0 | 179 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | −7 | −1 | −3 | −0 | 179 |
| Net financials | — | — | — | 0 | 2 |
| Profit before tax | −7 | −1 | −3 | −0 | 181 |
| Tax | −0 | −0 | −0 | — | −36 |
| Net profit | −7 | −1 | −3 | −0 | 145 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 23 | 23 | 20 | 13 | 208 |
| Equity | 18 | 17 | 13 | 13 | 158 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 5 | 6 | 6 | 0 | 49 |
| Total debt | 5 | 6 | 6 | — | 49 |
EBITDA margin
86.6%
This company
15.8%
Market median
+448% vs market
20202024
Equity ratio
76.2%
This company
38.2%
Market median
+99% vs market
20202024
Return on equity
91.7%
This company
18.4%
Market median
+398% vs market
20202024
Net profit margin
70.3%
This company
8.1%
Market median
+768% vs market
20202024
Asset turnover
0.99×
This company
1.12×
Market median
+12% vs market
20202024
Debt / equity
0.31×
This company
0.62×
Market median
+50% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-02-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Barsoum MedTech Services AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ebba Sara Elisabeth Barsoum | Board of Directors | 0 companies |
| Per Gustaf Felix Erlanson | Deputy Board Member | 0 companies |